Association between tumor molecular subtype, clinical stage and axillary pathological response in breast cancer patients undergoing complete pathological remission after neoadjuvant chemotherapy: potential implications for de-escalation of axillary surgery
Background: Axillary node status is used in clinical practice to guide the selection of axillary surgery in breast cancer patients. However, to date, the optimal axillary management following neoadjuvant therapy (NAT) for breast cancer remains controversial. Our study aimed to investigate the associ...
Main Authors: | Jin Hong, Yiwei Tong, Jianrong He, Xiaosong Chen, Kunwei Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-02-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758835921996673 |
Similar Items
-
The implications of a pathological complete response of the primary tumour after neoadjuvant chemotherapy for breast cancer on axillary surgery
by: Mina M. G. Youssef, et al.
Published: (2021-02-01) -
A Long Noncoding RNA Signature That Predicts Pathological Complete Remission Rate Sensitively in Neoadjuvant Treatment of Breast Cancer
by: Gen Wang, et al.
Published: (2017-12-01) -
Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer
by: Vijayashree Murthy, et al.
Published: (2021-08-01) -
Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients
by: Chao You, et al.
Published: (2017-10-01) -
Accurate Prediction of Neoadjuvant Chemotherapy Pathological Complete Remission (pCR) for the Four Sub-Types of Breast Cancer
by: Xin Feng, et al.
Published: (2019-01-01)